BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18046705)

  • 1. Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide.
    Liu G; Li Y; Pagel MD
    Magn Reson Med; 2007 Dec; 58(6):1249-56. PubMed ID: 18046705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring in vivo tumor pHe with CEST-FISP MRI.
    Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
    Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved pH measurements with a single PARACEST MRI contrast agent.
    Sheth VR; Liu G; Li Y; Pagel MD
    Contrast Media Mol Imaging; 2012; 7(1):26-34. PubMed ID: 22344877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biomarker-responsive T
    Daryaei I; Randtke EA; Pagel MD
    Magn Reson Med; 2017 Apr; 77(4):1665-1670. PubMed ID: 27090199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
    Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
    Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.
    Liu G; Li Y; Sheth VR; Pagel MD
    Mol Imaging; 2012 Feb; 11(1):47-57. PubMed ID: 22418027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Frequency-Selective pH-Responsive paraCEST Agent.
    Ratnakar SJ; Chirayil S; Funk AM; Zhang S; Queiró JF; Geraldes CFGC; Kovacs Z; Sherry AD
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21671-21676. PubMed ID: 32726500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-responsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome.
    Yoo B; Raam MS; Rosenblum RM; Pagel MD
    Contrast Media Mol Imaging; 2007 Jul; 2(4):189-98. PubMed ID: 17712869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.
    Li AX; Suchy M; Li C; Gati JS; Meakin S; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2011 Jul; 66(1):67-72. PubMed ID: 21254213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized MRI contrast for on-resonance proton exchange processes of PARACEST agents in biological systems.
    Li AX; Suchy M; Jones CK; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2009 Nov; 62(5):1282-91. PubMed ID: 19780147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lanthanide complexes of triethylenetetramine tetra-, penta-, and hexaacetamide ligands as paramagnetic chemical exchange-dependent saturation transfer contrast agents for magnetic resonance imaging: nona- versus decadentate coordination.
    Burdinski D; Pikkemaat JA; Lub J; de Peinder P; Nieto Garrido L; Weyhermüller T
    Inorg Chem; 2009 Jul; 48(14):6692-712. PubMed ID: 19507818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
    Winter PM; Cai K; Chen J; Adair CR; Kiefer GE; Athey PS; Gaffney PJ; Buff CE; Robertson JD; Caruthers SD; Wickline SA; Lanza GM
    Magn Reson Med; 2006 Dec; 56(6):1384-8. PubMed ID: 17089356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
    Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
    Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology.
    Winter PM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):389-98. PubMed ID: 22422650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of a PARACEST agent for MRI through selective outersphere interactions with phosphate diesters.
    Huang CH; Hammell J; Ratnakar SJ; Sherry AD; Morrow JR
    Inorg Chem; 2010 Jul; 49(13):5963-70. PubMed ID: 20509631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity.
    Li Y; Sheth VR; Liu G; Pagel MD
    Contrast Media Mol Imaging; 2011; 6(4):219-28. PubMed ID: 21861282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWIFT-CEST: a new MRI method to overcome T₂ shortening caused by PARACEST contrast agents.
    Soesbe TC; Togao O; Takahashi M; Sherry AD
    Magn Reson Med; 2012 Sep; 68(3):816-21. PubMed ID: 22213371
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.